Session

IBD (Posters)

MEDICATION ADHERENCE IN INFLAMMATORY BOWEL DISEASES IN THE ERA OF BIOTHERAPIES
MEDICATION ADHERENCE IN INFLAMMATORY BOWEL DISEASES IN THE ERA OF BIOTHERAPIES

PREVALENCE AND RISK FACTORS FOR FATIGUE IN CHRONIC INFLAMMATORY BOWEL DISEASE
PREVALENCE AND RISK FACTORS FOR FATIGUE IN CHRONIC INFLAMMATORY BOWEL DISEASE

SLEEP DISORDERS AND CHRONIC INFLAMMATORY BOWEL DISEASE: WHAT'S THE CONNECTION?
SLEEP DISORDERS AND CHRONIC INFLAMMATORY BOWEL DISEASE: WHAT'S THE CONNECTION?

SEXUAL DYSFUNCTION IN CHRONIC INFLAMMATORY BOWEL DISEASE: MYTH OR REALITY?
SEXUAL DYSFUNCTION IN CHRONIC INFLAMMATORY BOWEL DISEASE: MYTH OR REALITY?

THE EFFECT OF TREATMENT WITH TNF-ALPHA INHIBITORS ON BONE TURNOVER AND BONE MINERAL DENSITY (BMD) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
THE EFFECT OF TREATMENT WITH TNF-ALPHA INHIBITORS ON BONE TURNOVER AND BONE MINERAL DENSITY (BMD) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)
ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)

NON-IBD CHANGES IN THE ORAL MUCOSA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES. A CROSS SECTIONAL STUDY IN POLISH PATIENTS
NON-IBD CHANGES IN THE ORAL MUCOSA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES. A CROSS SECTIONAL STUDY IN POLISH PATIENTS

WHAT IS THE ROLE OF ANTI-TNF ALPHA IN CORRECTING ANEMIA IN CROHN'S DISEASE?
WHAT IS THE ROLE OF ANTI-TNF ALPHA IN CORRECTING ANEMIA IN CROHN'S DISEASE?

COLON-INVOLVING VERSUS NON-COLON-INVOLVING CROHN'S DISEASE CLASSIFICATION: IS THE MONTREAL CLASSIFICATION OUTDATED?
COLON-INVOLVING VERSUS NON-COLON-INVOLVING CROHN'S DISEASE CLASSIFICATION: IS THE MONTREAL CLASSIFICATION OUTDATED?

DIAGNOSTIC DELAY, EFFECTIVENESS AND SAFETY OUTCOMES IN A REAL-WORLD COHORT OF PATIENTS WITH CROHN'S DISEASE: DATA FROM ADMINISTRATIVE DATABASES IN TUSCANY, ITALY
DIAGNOSTIC DELAY, EFFECTIVENESS AND SAFETY OUTCOMES IN A REAL-WORLD COHORT OF PATIENTS WITH CROHN'S DISEASE: DATA FROM ADMINISTRATIVE DATABASES IN TUSCANY, ITALY

VOLUNTARY EXERCISE COMBINED WITH CONCOMITANT ALKALINE PHOSPHATASE TREATMENT RESOLVES EXPERIMENTAL COLITIS IN OBESE MICE BY IMPROVING COLONIC MICROCIRCULATION AND ATTENUATING INFLAMMATION, OXIDATIVE STRESS, AND RESTORATION OF ADIPONECTIN/LEPTIN RATIO
VOLUNTARY EXERCISE COMBINED WITH CONCOMITANT ALKALINE PHOSPHATASE TREATMENT RESOLVES EXPERIMENTAL COLITIS IN OBESE MICE BY IMPROVING COLONIC MICROCIRCULATION AND ATTENUATING INFLAMMATION, OXIDATIVE STRESS, AND RESTORATION OF ADIPONECTIN/LEPTIN RATIO

MANAGEMENT AND OUTCOME OF ABDOMINAL SURGERY IN COMPLICATED CROHN'S DISEASE
MANAGEMENT AND OUTCOME OF ABDOMINAL SURGERY IN COMPLICATED CROHN'S DISEASE

TRANSFORMATION OF FECAL MICROBIOTA COMPOSITION DUE TO BOWEL PREPARATION WITH MAGNESIUM-OXID AND SODIUM PICOSULFATE AMONGST PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TRANSFORMATION OF FECAL MICROBIOTA COMPOSITION DUE TO BOWEL PREPARATION WITH MAGNESIUM-OXID AND SODIUM PICOSULFATE AMONGST PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PRECISION DIAGNOSTICS IN IBD: METABOLOMIC AND GENETIC PROFILING
PRECISION DIAGNOSTICS IN IBD: METABOLOMIC AND GENETIC PROFILING

HS-GC/MS-BASED METABOLOMICS APPROACH FOR VOLATILE COMPOUNDS ANALYSIS IN IBD
HS-GC/MS-BASED METABOLOMICS APPROACH FOR VOLATILE COMPOUNDS ANALYSIS IN IBD

EVALUATION OF TROUGH LEVEL AND DISEASE ACTIVITY AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
EVALUATION OF TROUGH LEVEL AND DISEASE ACTIVITY AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

COLECTOMY PREDICTIVE FACTORS IN ACUTE SEVERE COLITIS
COLECTOMY PREDICTIVE FACTORS IN ACUTE SEVERE COLITIS

FEATURES OF THE COURSE OF COVID-19 IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH HERPESVIRUS LESIONS
FEATURES OF THE COURSE OF COVID-19 IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH HERPESVIRUS LESIONS

PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY
PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY

PREDICCT COHORT BASELINE HABITUAL NUTRIENT INTAKE BY IBD PATIENTS
PREDICCT COHORT BASELINE HABITUAL NUTRIENT INTAKE BY IBD PATIENTS

Item 1 - 20 / 568
1
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29